JP2016513642A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513642A5
JP2016513642A5 JP2016500713A JP2016500713A JP2016513642A5 JP 2016513642 A5 JP2016513642 A5 JP 2016513642A5 JP 2016500713 A JP2016500713 A JP 2016500713A JP 2016500713 A JP2016500713 A JP 2016500713A JP 2016513642 A5 JP2016513642 A5 JP 2016513642A5
Authority
JP
Japan
Prior art keywords
amino
pharmaceutical composition
compound according
item
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500713A
Other languages
English (en)
Japanese (ja)
Other versions
JP6482523B2 (ja
JP2016513642A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/021064 external-priority patent/WO2014158952A1/en
Publication of JP2016513642A publication Critical patent/JP2016513642A/ja
Publication of JP2016513642A5 publication Critical patent/JP2016513642A5/ja
Application granted granted Critical
Publication of JP6482523B2 publication Critical patent/JP6482523B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500713A 2013-03-13 2014-03-06 抗生物質化合物の塩酸塩 Active JP6482523B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361779065P 2013-03-13 2013-03-13
US61/779,065 2013-03-13
PCT/US2014/021064 WO2014158952A1 (en) 2013-03-13 2014-03-06 Hydrochloride salts of an antibiotic compound

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017028372A Division JP2017082016A (ja) 2013-03-13 2017-02-17 抗生物質化合物の塩酸塩

Publications (3)

Publication Number Publication Date
JP2016513642A JP2016513642A (ja) 2016-05-16
JP2016513642A5 true JP2016513642A5 (cg-RX-API-DMAC7.html) 2017-03-30
JP6482523B2 JP6482523B2 (ja) 2019-03-13

Family

ID=50483481

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016500713A Active JP6482523B2 (ja) 2013-03-13 2014-03-06 抗生物質化合物の塩酸塩
JP2017028372A Withdrawn JP2017082016A (ja) 2013-03-13 2017-02-17 抗生物質化合物の塩酸塩
JP2018153560A Withdrawn JP2018177817A (ja) 2013-03-13 2018-08-17 抗生物質化合物の塩酸塩

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017028372A Withdrawn JP2017082016A (ja) 2013-03-13 2017-02-17 抗生物質化合物の塩酸塩
JP2018153560A Withdrawn JP2018177817A (ja) 2013-03-13 2018-08-17 抗生物質化合物の塩酸塩

Country Status (32)

Country Link
US (1) US9161990B2 (cg-RX-API-DMAC7.html)
EP (1) EP2968446B1 (cg-RX-API-DMAC7.html)
JP (3) JP6482523B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150126659A (cg-RX-API-DMAC7.html)
CN (1) CN105120883B (cg-RX-API-DMAC7.html)
AR (1) AR095044A1 (cg-RX-API-DMAC7.html)
AU (1) AU2014241481B9 (cg-RX-API-DMAC7.html)
BR (1) BR112015022716A2 (cg-RX-API-DMAC7.html)
CA (1) CA2902720A1 (cg-RX-API-DMAC7.html)
CY (1) CY1119316T1 (cg-RX-API-DMAC7.html)
DK (1) DK2968446T3 (cg-RX-API-DMAC7.html)
EA (1) EA027282B1 (cg-RX-API-DMAC7.html)
ES (1) ES2633964T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20186874B (cg-RX-API-DMAC7.html)
HR (1) HRP20171188T1 (cg-RX-API-DMAC7.html)
HU (1) HUE033738T2 (cg-RX-API-DMAC7.html)
IL (1) IL240663A0 (cg-RX-API-DMAC7.html)
LT (1) LT2968446T (cg-RX-API-DMAC7.html)
MD (1) MD4599C1 (cg-RX-API-DMAC7.html)
ME (1) ME02854B (cg-RX-API-DMAC7.html)
MX (1) MX361984B (cg-RX-API-DMAC7.html)
PH (1) PH12015502060A1 (cg-RX-API-DMAC7.html)
PL (1) PL2968446T3 (cg-RX-API-DMAC7.html)
PT (1) PT2968446T (cg-RX-API-DMAC7.html)
RS (1) RS56141B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201507235YA (cg-RX-API-DMAC7.html)
SI (1) SI2968446T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201700369T1 (cg-RX-API-DMAC7.html)
TW (1) TWI608845B (cg-RX-API-DMAC7.html)
UA (1) UA115086C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014158952A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201506748B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016154100A1 (en) * 2015-03-24 2016-09-29 Elevance Renewable Sciences, Inc. Polyol esters of metathesized fatty acids and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434287A (en) * 1975-02-20 1984-02-28 Ciba-Geigy Corporation Cephalosporin derivatives
AR228726A1 (es) 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
US4626534A (en) 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
DE3801179A1 (de) 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
JPH0331449A (ja) 1989-06-27 1991-02-12 Yamaha Corp リードフレーム用Fe―Ni合金
EP0421297B1 (en) 1989-09-30 1993-12-01 Eisai Co., Ltd. Injectable preparations containing cephalosporin medicament and the use thereof
JPH03193735A (ja) 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
JP4142149B2 (ja) 1997-07-10 2008-08-27 明治製菓株式会社 バンコマイシンの凍結乾燥製剤
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
DE602004028111D1 (de) * 2003-04-16 2010-08-26 Sandoz Ag Verfahren zur herstellung von cefepim
JP2007500222A (ja) 2003-05-23 2007-01-11 セラヴァンス インコーポレーテッド 架橋グリコペプチド−セファロスポリン抗生物質
US6878868B2 (en) 2003-06-24 2005-04-12 Mcmillan Stacy L. Portable high-hat device
WO2005005436A2 (en) 2003-07-11 2005-01-20 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
TWI342312B (en) 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative
EP1656930A1 (en) 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
US20080103121A1 (en) 2006-10-30 2008-05-01 Gole Dilip J Cephalosporin derivative formulation
FR2932177B1 (fr) 2008-06-06 2012-11-30 Inst Francais Du Petrole Procede d'hydrogenation selective sur un catalyseur contenant de l'or.
JP2010105965A (ja) 2008-10-30 2010-05-13 Taiyo Yakuhin Kogyo Kk バンコマイシン製剤
WO2011035108A1 (en) 2009-09-17 2011-03-24 Eagle Pharmaceuticals, Inc. Formulations of daptomycin
EP2504020A4 (en) 2009-11-23 2013-05-29 Eagle Pharmaceuticals Inc Daptomycin FORMULATIONS

Similar Documents

Publication Publication Date Title
JP2014167010A5 (cg-RX-API-DMAC7.html)
JP2015520769A5 (cg-RX-API-DMAC7.html)
JP2017531038A5 (cg-RX-API-DMAC7.html)
JP2016515561A5 (cg-RX-API-DMAC7.html)
JP2013520405A5 (cg-RX-API-DMAC7.html)
JP2016516074A5 (cg-RX-API-DMAC7.html)
JP2014051497A5 (cg-RX-API-DMAC7.html)
JP2012513416A5 (cg-RX-API-DMAC7.html)
JP2015537020A5 (cg-RX-API-DMAC7.html)
JP2016505637A5 (cg-RX-API-DMAC7.html)
JP2015517489A5 (cg-RX-API-DMAC7.html)
RU2018114480A (ru) Соли и твердые формы монобактамного антибиотика
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2012115277A5 (cg-RX-API-DMAC7.html)
JP2015521617A5 (cg-RX-API-DMAC7.html)
JP2015051983A5 (cg-RX-API-DMAC7.html)
JP2013542981A5 (cg-RX-API-DMAC7.html)
JP2016505044A5 (cg-RX-API-DMAC7.html)
JP2017500289A5 (cg-RX-API-DMAC7.html)
JP2014503593A5 (cg-RX-API-DMAC7.html)
JP2015521156A5 (cg-RX-API-DMAC7.html)
JP2015511957A5 (cg-RX-API-DMAC7.html)
CN109689652A (zh) 稠杂环类衍生物、其制备方法及其在医学上的应用
EA201992771A1 (ru) Ингибитор поверхностного антигена вируса гепатита b
RU2018101473A (ru) Депо-препарат, содержащий сложный эфир лимонной кислоты